Cerner announces quarterly dividend

KANSAS CITY, Mo., May 19, 2021 (GLOBE NEWSWIRE) – Cerner Corporation (Nasdaq: CERN), a global health technology company, today announced that its board of directors has declared a cash dividend to shareholders of $ 0.22 per issue and in circulation. share. The cash dividend will be payable on July 13, 2021 to shareholders of record at the close of business on June 28, 2021.

Cerner intends to pay regular quarterly cash dividends, with future declarations subject to the approval of the Board of Directors and their determination that the declaration of dividends remains in the best interests of Cerner and its shareholders. The decision whether or not to pay future dividends and the amount of such dividends will be based on the financial condition of the company, results of operations, cash flow, capital requirements, applicable law and any other factors. that the board may deem relevant.

About Cerner

Cerner Corporation’s healthcare technologies connect people and information systems in thousands of contracted provider facilities around the world, dedicated to creating smarter, better care for individuals and communities . Recognized worldwide for its innovation, Cerner assists clinicians in making healthcare decisions and assists organizations in managing the health of their populations. The company also offers an integrated clinical and financial system to help manage day-to-day revenue functions, as well as a wide range of services to meet people-focused clinical, financial and operational needs. For more information visit, The Cerner Blog or log on Facebook, Instagram, LinkedIn, Twitter or The Cerner Podcast. Nasdaq: CERN. Health care is too important to stay the same.

All statements in this press release that do not relate directly and exclusively to historical facts constitute forward-looking statements. These forward-looking statements are based on the current beliefs, expectations and assumptions of Cerner’s management regarding future events and are subject to a number of important risks and uncertainties. It is important to note that Cerner’s actual performance and results, financial condition or business could differ materially from those expressed in these forward-looking statements. The words “intends”, “future” or the negative of these words, variations thereof or similar expressions are intended to identify these forward-looking statements. For example, our forward-looking statements include statements regarding future dividends. Factors that could cause or contribute to such differences include, but are not limited to, the extent to which the COVID-19 pandemic and the actions taken in response to it could adversely affect our financial condition, our future reservations and operating results; the possibility of disruption to our data centers or customer support facilities, or those of third parties with whom we have contracts (such as public cloud providers), which could subject us to significant costs and damage to reputation; the possibility of increased expenses, exposure to legal claims and regulatory actions, and reputational damage associated with a cyber attack or other breach of our IT security or the IT security of third parties on whom we count; potential claims for system errors and warranties or for significant costs and reputational damage related to product and service liabilities; material adverse resolution of legal proceedings or other claims or damage to reputation arising from negative publicity relating to such claims or legal proceedings; risks associated with our global operations, including, without limitation, greater difficulty in collecting accounts receivable; strong competition and our ability to anticipate or react quickly to market changes, evolving technologies and changing prices and deployment methods and bring new solutions, devices, features and services to market competitive in a timely manner; the risks inherent in business acquisitions, strategic investments, collaborations and the inability to achieve planned synergies or divestments; manage growth in new markets in which we offer solutions, healthcare devices or services; long sales cycles for our solutions and services; risks related to our dependence on strategic relationships and third party suppliers, including any impact on the activities of this supplier resulting from the COVID-19 pandemic; risks associated with the loss or recruitment and retention of key personnel or the inability to successfully develop and execute succession planning to transition key associates and their knowledge, relationships and expertise; failure to achieve expected operational efficiencies and to maintain or improve operating expense reductions or business disruptions or adverse tax consequences associated with restructuring, realignment and cost reduction activities; changing political, economic and regulatory influences, which could impact the purchasing practices and operations of our customers and increase the costs of providing compliant solutions and services; failure to comply with laws, regulations or certain industry initiatives or failure to provide solutions or services to enable our customers to comply with laws or regulations applicable to their business; the risks inherent in contracting with government clients, including, but not limited to, meeting strict compliance and disclosure obligations, navigating complex procurement rules and processes, and defending against disputes offers; volatility and disruption resulting from economic or global market conditions, including the impact of the COVID-19 pandemic; risks associated with our unpaid and future debt, such as compliance with covenants, which may limit our flexibility to operate our business; the risk that our capital allocation strategy will not be fully implemented or will not increase long-term shareholder value; changes in tax laws, regulations or guidelines that could adversely affect our tax position and / or challenges to our tax position in the United States and non-US countries; the potential for losses resulting from asset impairment charges; potential variations in our sales forecasts from actual sales; the risks that our revenue growth will be lower than expected and / or that the revenue mix will shift to low margin revenue; changes in our quarterly operating results; and the risks associated with fluctuations in currency exchange rates. Further discussion of these and other risks, uncertainties and factors affecting Cerner’s business is contained in the documents filed by Cerner with the Securities and Exchange Commission. The reader should not place undue reliance on forward-looking statements, as statements speak only as of the date on which they are made. Except as required by law, Cerner assumes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unforeseen events or changes in our business, results of operations or our financial situation over time.

Investor contact:
Allan Kells, (816) 201-2445, [email protected]

Media contact:
Stephanie Greenwood, Media Relations, [email protected]

Previous Germany's long pandemic school closures hit migrant students hardest
Next Commodity stocks and inflation data drag FTSE 100 down